The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

The prognostic impact of reduced variant burden in elderly patients with acute myeloid leukemia treated with decitabine

Background/Aims We evaluated the role of next-generation sequencing (NGS)-based disease monitoring for elderly patients diagnosed with acute myeloid leukemia (AML) who received decitabine therapy. Methods A total of 123 patients aged > 65 years with AML who received decitabine were eligible. We a...

Full description

Bibliographic Details
Main Authors: Mihee Kim, TaeHyung Kim, Seo-Yeon Ahn, Jun Hyung Lee, Ju Heon Park, Myung-Geun Shin, Sung-Hoon Jung, Ga-Young Song, Deok-Hwan Yang, Je-Jung Lee, Seung Hyun Choi, Mi Yeon Kim, Jae-Sook Ahn, Hyeoung-Joon Kim, Dennis Dong Hwan Kim
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2023-07-01
Series:The Korean Journal of Internal Medicine
Subjects:
acute myeloid leukemia
elderly patients
decitabine
allele frequency
residual neoplasm
Online Access:http://kjim.org/upload/kjim-2022-396.pdf

Internet

http://kjim.org/upload/kjim-2022-396.pdf

Similar Items